NIH Reporter #PA-23-260

NIH grant for research on osmosensing in GI enteroendocrine cells

This opportunity from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of NIH, supports research into osmosensing mechanisms in gastrointestinal enteroendocrine cells. - Government Buyer: - National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH - Vendors and OEMs: - No specific OEMs or commercial vendors are named; Mayo Clinic Rochester is mentioned as a prospective bidder - Products/Services Requested: - Research service: Investigation of cellular pathways and signaling molecules involved in osmosensing in GI enteroendocrine cells - Principal investigator: Shreya Bellampalli - Estimated contract value: $49,738 - Unique/Notable Requirements: - Focus on digestive diseases and nutrition research - Opportunity is open for applications - Intended to advance understanding of gut-brain interaction disorders - No specific part numbers or product quantities are listed, as this is a research grant

Description

This funding opportunity supports research into the mechanisms of osmosensing in gastrointestinal enteroendocrine cells. The research aims to uncover cellular pathways and signaling molecules involved in osmotic stimuli detection and response. The goal is to advance understanding with potential implications for treating gut-brain interaction disorders. The solicitation is open for applications with an expected award notice date of August 19, 2025.

View original listing